Patent & License Managers
Patent- & License Managers Life Science
Patent & License Managers Physics/Chemistry/Technology/Software
Technology-/IP-Analyst
Together with Egenhard Link and Matthias Stein-Gerlach, Dieter Link is responsible for technology transfer in the life-sciences section. Prior to working for Max Planck Innovation he held various positions with Xantos Biomedicine AG in Munich and, among others, has been responsible for the implementation of novel cell-based assay technologies and for establishing the company's metabolic disease program.
He studied microbiology, biochemistry and human genetics at the Johann Wolfgang Goethe University in Frankfurt, where he wrote his doctoral thesis at the University's Institute of Human Genetics. During his academic career, he initially focused on the control of gene expression in microorganisms, and later on cellular differentiation mechanisms in mammals.
Dieter Link joined Max Planck Innovation in February 2006.
Together with Dieter Link and Matthias Stein-Gerlach, Egenhard Link is responsible for technology transfer in the life-sciences section. He studied Biology (final exams in Zoology, Biochemistry, Molecular Cell Biology and Pharmacology) at the Technical University and Ludwig Maximilians University in Munich, and wrote his diploma thesis at the Max Planck Institute of Biochemistry in Martinsried. His research focus was on the isolation and characterization of a protein which inhibits the transcription factor NF-kappaB.
For his doctoral thesis and as postdoc, he conducted research at Yale University in New Haven, Connecticut (USA), for five years, elucidating, among other things, the molecular mechanisms of action of tetanus and botulinum neurotoxins. Subsequently, he became research associate at the Max Planck Institute for Experimental Medicine in Göttingen and then founder of "Synaptic Systems", a small albeit profitable biotech start-up.
Egenhard Link joined Max Planck Innovation in September 2000.
Together with Dieter Link and Egenhard Link, Matthias Stein-Gerlach is responsible for technology transfer in the life-sciences section. He is co-founder of the biotech companies Axxima Pharmaceuticals AG, Munich, and U3 Pharmaceuticals AG, Martinsried. After heading his own research group at Axxima, starting 1998, he became Director Business Development in 2001 and was appointed VP Business Development in 2002, heading the business development department until 2004.
He studied molecular biology in Mainz and earned his PhD in 1998 in the lab of Dr Axel Ullrich of Max Planck Institute for Biochemistry in Martinsried with a thesis focusing on signal transduction. In addition, Matthias Stein-Gerlach has completed a 3 year education in finance and administration at the Adam Opel AG.
Matthias Stein-Gerlach joined Max Planck Innovation in April 2004.
Together with Dieter Link, Egenhard Link and Matthias Stein-Gerlach, Mareike Göritz is responsible for technology transfer in the life-sciences section. She studied chemistry at the universities of Erlangen-Nuremberg, Valencia (Spain) and California, Berkeley (USA). She obtained her PhD in bioinorganic chemistry from the University of Heidelberg where she worked on functionalized nucleic acids for sequence-specific detection of DNA. As a postdoctoral researcher at the California Institute of Technology in Pasadena she studied the regulation of gene transcription by small DNA-binding molecules in living cells.
Mareike Göritz joined Max Planck Innovation in July 2009.
Together with Wolfgang Tröger, Bernd Ctortecka is responsible for technology transfer in the chemistry, physics and technology section, as well as for the know-how transfer of software from the Max Planck Society.
Bernd Ctortecka began his career in banking. He then studied physics at the Albert Ludwigs University in Freiburg i.Br. and at the University of St. Andrews, Scotland, UK, and completed his Master of Philosophy (M.Phil) with a thesis on NMR studies of superconductors. He wrote his doctoral thesis on comparative studies of metal sites in copper proteins with synthetic macromolecules at the Faculty of Physics at Leipzig University, including regular stays at the isotope separator ISOLDE at CERN, Geneva, the Paul Scherrer Institute (PSI) in Villigen, Switzerland, and the Chalmers University Gothenburg. One aspect of the PSI collaboration was the development of a radio pharmacon based on the isotope 111Ag. Subsequently, he worked in a Munich-based patent law firm and became internal key account manager at Infineon Technologies AG.
Bernd Ctortecka joined Max Planck Innovation in January 2002.
Together with Bernd Ctortecka, Wolfgang Tröger is responsible for technology transfer in the chemistry, physics and technology section of the Max Planck Society. Following his physics studies at the Technical University of Munich (TUM), he earned his PhD at the Max Planck Institute for Biochemistry in Martinsried and the Physics Department of TUM. Following periods of research in Paris and Copenhagen, he habilitated at Leipzig University. His research interest focused on the application of nuclear techniques and other spectroscopic methods in the life, environmental and material sciences. The interdisciplinary approach of his research at the borderline between physics, chemistry and biology endowed him with a broad experience in these fields, which was an invaluable input for his industry cooperation.
Wolfgang Tröger joined Max Planck Innovation in September 2004.
Together with Wolfgang Tröger and Bernd Ctortecka, Lars Cuypers is responsible for technology transfer in the chemistry, physics and technology section. He studied chemistry at the Carl von Ossietzky University Oldenburg and devoted his diploma thesis to the field inorganic molecule chemistry. Than he changed to the Philipps University Marburg for his conferral of a doctorate focusing on hydrogallation and the synthesis of gallium clusters. He gained first business experience at the graduate program of the speciality chemistry company Clariant, working on different research and development projects regarding fields like metal working fluids, crop protection, personal care and detergents. The following function as a laboratory manager in the field detergent raw materials enabled him to contribute his services to major projects with direct customer contact.
Lars Cuypers joined Max Planck Innovation in May 2007.
Technology-/IP-Analyst
Dr Marco Mank has been working as a Technology/IP Analyst in the Life Sciences section of the Patent and License Management department since September 15th, 2010. Dr Mank studied at Julius-Maximilians-Universität in Würzburg. He then completed his doctorate in the Zellular Dynamics Research Group at the Max Planck Institute for Neurobiology in Martinsried, where he also worked as a post-doc. In this capacity he carried out research on the development of biosensors, in particular the optimization of genetically encoded calcium indicators. Dr Mank was awarded the Otto Hahn Medal for his doctoral thesis in 2008. This award is presented annually by the Max Planck Society for outstanding scientific achievements by junior scientists. Dr Mank will carry out patent and market research for the team at Max Planck Innovation until mid-September 2012.
Alexander Grundmeier works as a technology/IP analyst in the chemistry, physics and technology section of the patent and license management department. He studied physics at the Braunschweig University of Technology and the University of Göttingen. In Göttingen he wrote his diploma thesis in the field of quantum field theory. For his conferral of a doctorate Alexander Grundmeier changed to the Free University of Berlin, where he examined metalloproteins with X-ray absorption spectroscopy (BioXAS). Especially, he focused on the structure of the manganese complex of photosystem II. Additionally to measurements at synchrotron radiation sources, Alexander Grundmeier performed computer simulations of X-ray absorption spectra. Due to this interdisciplinary work he gained insights in various aspects of biochemistry, biophysics, and bioinorganic chemistry.
Alexander Grundmeier joined Max Planck Innovation in October 2011 and will carry out patent and market research for the patent and license management department until end of September 2013.
World-class science
Download
PDF, 0.24 MB
Guidelines for Knowledge and Technology Transfer
PDF, 5.32 MB
Guidelines for Inventors
PDF, 9.36 MB
Guidelines for Spin-offs